InvestorsHub Logo
Followers 5
Posts 351
Boards Moderated 0
Alias Born 12/18/2014

Re: None

Tuesday, 06/09/2015 6:46:04 AM

Tuesday, June 09, 2015 6:46:04 AM

Post# of 3108
This is not my post BUT taken from another board(just so you don't think I am this smart LOL)
I need to post this here so you can understand the value of NBS and why I have stuck with it 3 years even if I am way down on the stock(I do believe in the science)

Reading this first:
FDA panel gives a thumbs up to Amgen's T-Vec for melanoma http://www.fiercebiotech.com/story/fda-panel-gives-amgen-thumbs-t-vec-melanoma/2015-04-29

What you just read is valued at $1Billion Dollars!(The company that sold the technology got 1 billion for it. You probably have heard of T-VEC.)

Now here is the comparison of there treatment and NBS20

T-VEC Phase 2:
Overall survival was 54% at 1 year and 52% at 2 years—demonstrating that responses to T-VEC are quite durable.
T-VEC Phase 3 interim: Median survival of 23.3 Months

NBS20 Phase 2:
At two years, survival was 72% compared to 31% for control patients (p=0.007), which was consistent with the previous Phase 2 trial’s findings in which NBS20 demonstrated 73% two-year survival in 54 patients, with a median survival of 60 months.

If this does not tell you what a deal NBS is or should I say CLBS is I do not know what to say!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LSTA News